BillionToOne, Inc. (BLLN)
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics.
$135.94-0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+35.9%
The outlook
BillionToOne, Inc. currently reads as bullish based on buy — 1.8 avg of 7 analysts, above its 50- & 200-day averages, 95% of the way from its 52-week low to high, avg target -9% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 7 analysts
Price trendAbove its 50- & 200-day averages
52-week range95% of the way from its 52-week low to high
Price targetAvg target -9% vs current price
Analyst price target
~12-month · 7 analysts$123.86average target-8.9% vs now
Now $135.94
Low $90.00High $145.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$6.25B
52-wk high
$140.21
52-wk low
$61.96
50-day avg
$111.13
200-day avg
$94.39
Trailing P/E
251.7